Form 4: Century Therapeutics Insider Sells Shares
Insider Transaction Filing
Century Therapeutics President and CEO Brent Pfeiffenberger reported a transaction involving the withholding of shares to cover tax obligations.
Summary
- Brent Pfeiffenberger, President and CEO of Century Therapeutics, Inc., reported a transaction on June 5, 2026.
- This transaction involved shares withheld by the Issuer to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following this transaction, Mr. Pfeiffenberger beneficially owns 3,679,323 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard administrative transaction related to executive compensation and tax obligations, rather than a reflection of company performance or strategic shifts.
Future Outlook
No forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and do not typically provide strategic updates or financial performance data. This filing indicates a standard event related to executive compensation and tax management.
Key Dates
| Date | Description |
|---|---|
| 06/05/2026 | Earliest transaction date and transaction date for share withholding. |
| 06/09/2026 | Date of signature for the filing. |
Keywords
Century Therapeutics, IPSC, Form 4, Insider Transaction, Stock Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.